Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pleural Effusion, Malignant × Photochemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 21 Carcinoma, Basal Cell 8 Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 6 Cholangiocarcinoma 6 Skin Neoplasms 4 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Lung Neoplasms 3 Liver Neoplasms 3 Leukoplakia, Oral 3 Bile Duct Neoplasms 3 Warts 2 Tongue Neoplasms 2 Prostatic Neoplasms 2 Pleural Diseases 2 Neoplasms 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Bowen's Disease 2 Basal Cell Nevus Syndrome 2 Barrett Esophagus 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Skin Diseases 1

Interventions

Cisplatin 8 Carboplatin 7 Bevacizumab 7 Talc 6 Pleurodesis 6 Paclitaxel 5 Doxycycline 4 Docetaxel 4 Taxes 3 Gemcitabine 3 Zoledronic Acid 2 Trastuzumab 2 Thoracoscopy 2 Sodium Chloride 2 Silver Nitrate 2 Povidone-Iodine 2 Nivolumab 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Chest Tubes 2 Bortezomib 2 viscum album peptide 1 tocilizumab 1 tipifarnib 1 talimogene laherparepvec 1 romidepsin 1 rilotumumab 1 lipoplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02702700 2019-03-20

PDT-lipo

Centre Hospitalier Universitaire Vaudois

Phase 1 Terminated

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡